Legal Representation
Attorney
Janet W. Cho
USPTO Deadlines
Next Deadline
313 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-05-31)
Due Date
May 31, 2026
Grace Period Ends
November 30, 2026
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 1, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Jan 29, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Dec 3, 2022 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Dec 3, 2022 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Dec 1, 2022 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jun 1, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| May 19, 2022 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| May 31, 2021 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Aug 8, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 31, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 26, 2016 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 25, 2016 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 23, 2016 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 20, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 16, 2016 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 16, 2016 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 23, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 29, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 29, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 9, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 13, 2015 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 13, 2015 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 3, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 24, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 23, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 23, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 5, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 5, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 5, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 27, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 10, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 7, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 2, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations and substances for the treatment of inflammation, musculoskeletal, respiratory, and immune system related diseases and disorders; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and psychiatric diseases and disorders; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of rheumatoid arthritis and of all diseases and disorders related to rheumatoid arthritis; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders
First Use Anywhere:
Feb 24, 2016
First Use in Commerce:
Feb 24, 2016
Additional Information
Design Mark
The mark consists of the word "IMPAX" in a stylized font beginning with the capital letter "I" and followed by lower case letters. A circle surrounds the letters "pax" and is slightly bolder on the right side of the circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005